MedPath

GE MEDICAL SYSTEMS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram

Completed
Conditions
Breast Cancer
First Posted Date
2007-09-26
Last Posted Date
2010-05-14
Lead Sponsor
GE Healthcare
Target Recruit Count
400
Registration Number
NCT00535678
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Perfusion Imaging and CT -Understanding Relative Efficacy

Not Applicable
Terminated
Conditions
Coronary Artery Disease
Interventions
Device: 64 Channel VCT
First Posted Date
2007-06-14
Last Posted Date
2017-08-23
Lead Sponsor
GE Healthcare
Target Recruit Count
249
Registration Number
NCT00486447
Locations
🇺🇸

GE Healthcare, Waukesha, Wisconsin, United States

Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2007-03-05
Last Posted Date
2022-07-27
Lead Sponsor
GE Healthcare
Target Recruit Count
40
Registration Number
NCT00443001
Locations
🇺🇸

GE Healthcare, Milwaukee, Wisconsin, United States

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms

Phase 4
Completed
Conditions
Parkinsonian Syndromes
Interventions
Procedure: DaTSCAN SPECT imaging
First Posted Date
2006-10-02
Last Posted Date
2012-09-03
Lead Sponsor
GE Healthcare
Target Recruit Count
273
Registration Number
NCT00382967
Locations
🇫🇷

GE Healthcare, Velizy, France

Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches

Phase 4
Completed
Conditions
Coronary Artery Disease
Interventions
Drug: Technetium Tc99m Tetrofosmin injections
First Posted Date
2006-09-27
Last Posted Date
2007-12-05
Lead Sponsor
GE Healthcare
Target Recruit Count
291
Registration Number
NCT00381316
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT

Not Applicable
Terminated
Conditions
Coronary Artery Disease
Interventions
Device: 64 Channel VCT
First Posted Date
2006-07-10
Last Posted Date
2019-04-30
Lead Sponsor
GE Healthcare
Target Recruit Count
77
Registration Number
NCT00350506
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Phase 3
Terminated
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2006-07-04
Last Posted Date
2019-04-25
Lead Sponsor
GE Healthcare
Target Recruit Count
66
Registration Number
NCT00348608

A Study of Computed Tomography (CT) for Evaluation of Coronary Artery Blockages in Typical or Atypical Chest Pain

Not Applicable
Completed
Conditions
Coronary Artery Disease
Interventions
Device: 64 Channel VCT
First Posted Date
2006-07-04
Last Posted Date
2019-04-29
Lead Sponsor
GE Healthcare
Target Recruit Count
245
Registration Number
NCT00348569
Locations
🇺🇸

Robert Centofanti, MS, Princeton, New Jersey, United States

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Phase 3
Terminated
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2006-06-09
Last Posted Date
2019-04-25
Lead Sponsor
GE Healthcare
Target Recruit Count
89
Registration Number
NCT00335335

Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography

Phase 4
Withdrawn
Conditions
Coronary Artery Disease (CAD)
Renal Impairment
Diabetes Mellitus
First Posted Date
2006-06-08
Last Posted Date
2019-04-29
Lead Sponsor
GE Healthcare
Registration Number
NCT00335101
Locations
🇩🇪

GE Healthcare, Munich, Germany

© Copyright 2025. All Rights Reserved by MedPath